{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:13:26Z","timestamp":1788984806837,"version":"build-2803163510"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0208321","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:26:34Z","timestamp":1544117194000},"page":"e0208321","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":133,"title":["Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation"],"prefix":"10.1371","volume":"13","author":[{"given":"Ademuyiwa S.","family":"Aromolaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Al\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deana","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"El-Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Leopoldo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0146-4416","authenticated-orcid":true,"given":"Franco","family":"Laghi-Pasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Enea","family":"Lazzerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Boutjdir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,6]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"H2183","DOI":"10.1152\/ajpheart.00624.2003","article-title":"Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac function","volume":"287","author":"S Yang","year":"2004","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cyto.2014.12.024","article-title":"The varying faces of IL-6: From cardiac protection to cardiac failure","volume":"74","author":"JA Fontes","year":"2015","journal-title":"Cytokine"},{"issue":"Suppl 3","key":"ref3","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","article-title":"The paradigm of IL-6: from basic science to medicine","volume":"4","author":"T Naka","year":"2002","journal-title":"Arthritis Res"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/FJC.0b013e318068dd49","article-title":"Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling","volume":"50","author":"M Kurdi","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref5","article-title":"Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes","author":"PE Lazzerini","year":"2017","journal-title":"Heart (British Cardiac Society)"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3899\/jrheum.140861","article-title":"Association between corrected QT interval and inflammatory cytokines in rheumatoid arthritis","volume":"42","author":"AM Adlan","year":"2015","journal-title":"The Journal of rheumatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcvm.2015.00026","article-title":"Long QT Syndrome: An Emerging Role for Inflammation and Immunity","volume":"2","author":"PE Lazzerini","year":"2015","journal-title":"Frontiers in cardiovascular medicine"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/eurjhf\/hfq229","article-title":"Prognostic electrocardiographic parameters in patients with suspected myocarditis","volume":"13","author":"C Ukena","year":"2011","journal-title":"European journal of heart failure"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/acr.22455","article-title":"Antiarrhythmic potential of anticytokine therapy in rheumatoid arthritis: tocilizumab reduces corrected QT interval by controlling systemic inflammation","volume":"67","author":"PE Lazzerini","year":"2015","journal-title":"Arthritis care & research"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"e95994","DOI":"10.1371\/journal.pone.0095994","article-title":"Inflammation and prolonged QT time: results from the Cardiovascular Disease, Living and Ageing in Halle (CARLA) study","volume":"9","author":"D Medenwald","year":"2014","journal-title":"PloS one"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"e0151245","DOI":"10.1371\/journal.pone.0151245","article-title":"Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England","volume":"11","author":"M Pujades-Rodriguez","year":"2016","journal-title":"PloS one"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"H Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejim.2013.02.009","article-title":"Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis","volume":"24","author":"PE Lazzerini","year":"2013","journal-title":"European journal of internal medicine"},{"issue":"1","key":"ref14","first-page":"84","article-title":"Population-based study of QT interval prolongation in patients with rheumatoid arthritis","volume":"33","author":"K Chauhan","year":"2015","journal-title":"Clinical and experimental rheumatology"},{"issue":"22","key":"ref15","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"PE Lazzerini","year":"2017","journal-title":"European heart journal"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.autrev.2014.05.007","article-title":"Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation","volume":"13","author":"PE Lazzerini","year":"2014","journal-title":"Autoimmunity reviews"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/rheumatology\/ket338","article-title":"Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden","volume":"53","author":"VF Panoulas","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/art.39198","article-title":"Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative","volume":"67","author":"RH Mackey","year":"2015","journal-title":"Arthritis & rheumatology (Hoboken, NJ)"},{"issue":"5","key":"ref19","first-page":"715","article-title":"Elevated IL-1beta levels in anti-Ro\/SSA connective tissue diseases patients with prolonged corrected QTc interval","volume":"33","author":"CN Pisoni","year":"2015","journal-title":"Clinical and experimental rheumatology"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.hrthm.2016.01.012","article-title":"hERG 1a LQT2 C-terminus truncation mutants display hERG 1b-dependent dominant negative mechanisms","volume":"13","author":"A Puckerin","year":"2016","journal-title":"Heart Rhythm"},{"issue":"1","key":"ref21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0002-9343(00)00623-9","article-title":"Molecular biology of K(+) channels and their role in cardiac arrhythmias","volume":"110","author":"M Tristani-Firouzi","year":"2001","journal-title":"Am J Med"},{"key":"ref22","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","author":"PE Lazzerini","year":"2017","journal-title":"Nature reviews Cardiology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2015.09.002","article-title":"Role of pharmacotherapy in cardiac ion channelopathies","volume":"155","author":"N El-Sherif","year":"2015","journal-title":"Pharmacol Ther"},{"issue":"40","key":"ref24","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1093\/eurheartj\/eht089","article-title":"The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy","volume":"34","author":"PJ Schwartz","year":"2013","journal-title":"European heart journal"},{"issue":"14","key":"ref25","doi-asserted-by":"crossref","first-page":"13289","DOI":"10.1074\/jbc.C400025200","article-title":"Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator","volume":"279","author":"J Wang","year":"2004","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"H238","DOI":"10.1152\/ajpheart.01122.2006","article-title":"TNF-alpha downregulates transient outward potassium current in rat ventricular myocytes through iNOS overexpression and oxidant species generation","volume":"293","author":"M Fernandez-Velasco","year":"2007","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1253\/circj.70.605","article-title":"Tumor necrosis factor-alpha downregulates the voltage gated outward K+ current in cultured neonatal rat cardiomyocytes: a possible cause of electrical remodeling in diseased hearts","volume":"70","author":"H Kawada","year":"2006","journal-title":"Circulation journal: official journal of the Japanese Circulation Society"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/cvr\/27.3.525","article-title":"Effects of human recombinant interleukin-1 on electrical properties of guinea pig ventricular cells","volume":"27","author":"YH Li","year":"1993","journal-title":"Cardiovascular research"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"H2098","DOI":"10.1152\/ajpheart.00097.2005","article-title":"Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha","volume":"290","author":"PS Petkova-Kirova","year":"2006","journal-title":"American journal of physiology Heart and circulatory physiology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"13344","DOI":"10.1038\/ncomms13344","article-title":"Macrophage-dependent IL-1beta production induces cardiac arrhythmias in diabetic mice","volume":"7","author":"G Monnerat","year":"2016","journal-title":"Nature communications"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.yjmcc.2007.09.004","article-title":"SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL, [Ca2+]i transient, and APD increase in cardiomyocytes","volume":"43","author":"Y Hagiwara","year":"2007","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cvr\/cvu231","article-title":"LQT1 mutations in KCNQ1 C-terminus assembly domain suppress IKs using different mechanisms","volume":"104","author":"AS Aromolaran","year":"2014","journal-title":"Cardiovascular research"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.115.009800","article-title":"Pathogenesis of the Novel Autoimmune-Associated Long-QT Syndrome","volume":"132","author":"Y Yue","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bbrc.2016.04.113","article-title":"High-fat diet-dependent modulation of the delayed rectifier K(+) current in adult guinea pig atrial myocytes","volume":"474","author":"AS Aromolaran","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00424-008-0476-7","article-title":"Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the I (Kr) current","volume":"456","author":"AP Larsen","year":"2008","journal-title":"Pflugers Archiv: European journal of physiology"},{"issue":"8","key":"ref36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/aps.2010.84","article-title":"State-dependent blockade of human ether-a-go-go-related gene (hERG) K(+) channels by changrolin in stably transfected HEK293 cells","volume":"31","author":"WH Chen","year":"2010","journal-title":"Acta pharmacologica Sinica"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1085\/jgp.201010582","article-title":"hERG potassium channel gating is mediated by N- and C-terminal region interactions","volume":"137","author":"AS Gustina","year":"2011","journal-title":"The Journal of general physiology"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.cellsig.2010.03.009","article-title":"A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling","volume":"22","author":"N Szabo-Fresnais","year":"2010","journal-title":"Cell Signal"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0008-6363(01)00509-0","article-title":"Rapid component I(Kr) of the guinea-pig cardiac delayed rectifier K(+) current is inhibited by beta(1)-adrenoreceptor activation, via cAMP\/protein kinase A-dependent pathways","volume":"53","author":"CA Karle","year":"2002","journal-title":"Cardiovascular research"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2016.05.024","article-title":"Role of JAK-STAT pathway in reducing cardiomyocytes hypoxia\/reoxygenation injury induced by S1P postconditioning","volume":"784","author":"Y Wang","year":"2016","journal-title":"European journal of pharmacology"},{"issue":"10","key":"ref41","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/01.RES.84.10.1127","article-title":"Mechanical stretch activates the JAK\/STAT pathway in rat cardiomyocytes","volume":"84","author":"J Pan","year":"1999","journal-title":"Circ Res"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2014.09.048","article-title":"Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1alpha-VEGF mediated angiogenesis","volume":"355","author":"X Bai","year":"2014","journal-title":"Cancer letters"},{"issue":"6","key":"ref43","first-page":"619","article-title":"Review: The Prolonged QT Interval: Role of Pro-inflammatory Cytokines, Reactive Oxygen Species and the Ceramide and Sphingosine-1 Phosphate Pathways","volume":"29","author":"PP Sordillo","year":"2015","journal-title":"vivo (Athens, Greece)"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yjmcc.2009.02.025","article-title":"Ventricular K+ currents are reduced in mice with elevated levels of serum TNFalpha","volume":"47","author":"SA Grandy","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3389\/fphys.2017.00334","article-title":"TNFalpha Modulates Cardiac Conduction by Altering Electrical Coupling between Myocytes","volume":"8","author":"SA George","year":"2017","journal-title":"Frontiers in physiology"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"H431","DOI":"10.1152\/ajpheart.00431.2002","article-title":"Calcium-dependent arrhythmias in transgenic mice with heart failure","volume":"284","author":"B London","year":"2003","journal-title":"American journal of physiology Heart and circulatory physiology"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1011401825680","article-title":"The role of interleukin-6 in the failing heart","volume":"6","author":"KC Wollert","year":"2001","journal-title":"Heart failure reviews"},{"issue":"6","key":"ref48","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The role and therapeutic targeting of IL-6 in rheumatoid arthritis","volume":"13","author":"M Narazaki","year":"2017","journal-title":"Expert review of clinical immunology"},{"key":"ref49","first-page":"1","article-title":"Efficacy and tolerability of six-week extended dosing interval with tocilizumab therapy in a prospective cohort as remission maintenance in patients with rheumatoid arthritis","author":"J Kikuchi","year":"2017","journal-title":"Modern rheumatology"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/08830185.2014.938325","article-title":"Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights","volume":"34","author":"M Hashizume","year":"2015","journal-title":"International reviews of immunology"},{"issue":"30","key":"ref51","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","article-title":"Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial","volume":"37","author":"O Kleveland","year":"2016","journal-title":"European heart journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0208321","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:53:52Z","timestamp":1775296432000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0208321"}},"subtitle":[],"editor":[{"given":"Alexander G.","family":"Obukhov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,6]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0208321","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,6]]}}}